药品安全市场：按功能（ADR 报告、药品安全审核、完全整合软体）、按交付型态（按需、内部部署）、按最终用户划分 - 2023-2030 年全球预测

全球药品安全市场预计将大幅成长，预计2023年将达到115.6364亿美元，年复合成长率为21.68%，预计2030年将达到457.4638亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球药品安全市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球药品安全市场规模及预测为何？

2. 在预测期内，COVID-19 对全球药品安全市场的阻碍因素与影响有哪些？

3. 预测期内全球药品安全市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球药品安全市场的竞争策略是什么？

5. 全球药品安全市场的技术趋势和法律规范是什么？

6.全球药品安全市场主要厂商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球药品安全市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 吸烟成瘾症的人口增加
    • 病人安全问题日益严重
    • 玩家对外包服务的需求不断成长
  • 抑制因素
    • 临床试验问题
  • 机会
    • 活性化研发活动
    • 提高药物安全性，推动新药上市
  • 任务
    • 药物副作用
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章药品安全市场的功能

• ADR 报告
• 药品安全审核
• 完全整合的软体
• 问题追踪

第7章依交付模式分類的药品安全市场

• 一经请求
• 本地

第8章药品安全市场：依最终用户分类

• 业务流程外包
• 合约研究组织
• 製药和生物技术公司

第9章美洲药品安全市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太药品安全市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲、中东和非洲药品安全市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可证和定价

The Global Drug Safety Market is forecasted to grow significantly, with a projected USD 11,563.64 million in 2023 at a CAGR of 21.68% and expected to reach a staggering USD 45,746.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Safety Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Safety Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Functionality, market is studied across ADR Reporting, Drug Safety Audits, Fully Integrated Software, and Issue Tracking. The Fully Integrated Software is projected to witness significant market share during forecast period.

Based on Delivery Mode, market is studied across On-Demand and On-Premise. The On-Demand is projected to witness significant market share during forecast period.

Based on End User, market is studied across Business Process Outsourcing, Contract Research Organizations, and Pharma & Biotech Companies. The Contract Research Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Safety Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Safety Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Safety Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Safety Market?

4. What is the competitive strategic window for opportunities in the Global Drug Safety Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Safety Market?

6. What is the market share of the leading vendors in the Global Drug Safety Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Safety Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Drug Safety Market, by Functionality, 2022 vs 2030
• 4.3. Drug Safety Market, by Delivery Mode, 2022 vs 2030
• 4.4. Drug Safety Market, by End User, 2022 vs 2030
• 4.5. Drug Safety Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing population addicted to smoking
    • 5.1.1.2. Escalating patient safety issues
    • 5.1.1.3. Rise in demand for outsourcing services by players
  • 5.1.2. Restraints
    • 5.1.2.1. Issues related to clinical trials
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities
    • 5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects of drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Drug Safety Market, by Functionality

• 6.1. Introduction
• 6.2. ADR Reporting
• 6.3. Drug Safety Audits
• 6.4. Fully Integrated Software
• 6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode

• 7.1. Introduction
• 7.2. On-Demand
• 7.3. On-Premise

8. Drug Safety Market, by End User

• 8.1. Introduction
• 8.2. Business Process Outsourcing
• 8.3. Contract Research Organizations
• 8.4. Pharma & Biotech Companies

9. Americas Drug Safety Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Safety Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DRUG SAFETY MARKET RESEARCH PROCESS
• FIGURE 2. DRUG SAFETY MARKET SIZE, 2022 VS 2030
• FIGURE 3. DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2030 (%)
• FIGURE 5. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2022 VS 2030 (%)
• FIGURE 6. DRUG SAFETY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. DRUG SAFETY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. DRUG SAFETY MARKET DYNAMICS
• FIGURE 9. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. DRUG SAFETY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DRUG SAFETY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 5. DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 10. DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. DRUG SAFETY MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS , BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 27. CANADA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 44. CHINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 47. INDIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 99. ITALY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 111. POLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 114. QATAR DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. DRUG SAFETY MARKET LICENSE & PRICING